Logo
x

Search category

Subscribe Now

All Posts by Date

Disease of the Month: Age-Related Macular Degeneration

Disease of the Month: Age-Related Macular Degeneration

  • February 9, 2023
Cara Therapeutics Reports P-II Trial (KOMFORT) of Difelikefalin for Pruritus in Notalgia Paresthetica Published in the NEJM

Cara Therapeutics Reports P-II Trial (KOMFORT) of Difelikefalin for Pruritus in Notalgia Paresthetica Published in the NEJM

  • February 9, 2023
Alvotech and STADA Report EMA Acceptance of MAA for AVT04, a Proposed Biosimilar to Stelara (ustekinumab)

Alvotech and STADA Report EMA Acceptance of MAA for AVT04, a Proposed Biosimilar to Stelara (ustekinumab)

  • February 9, 2023
Galapagos Reports P-III Trial (DIVERSITY) Results of Filgotinib for the Treatment of Crohn’s Disease

Galapagos Reports P-III Trial (DIVERSITY) Results of Filgotinib for the Treatment of Crohn’s Disease

  • February 9, 2023
NICE Failed to Recommend Boehringer Ingelheim and Lilly’s Jardiance (empagliflozin) for Heart Failure

NICE Failed to Recommend Boehringer Ingelheim and Lilly’s Jardiance (empagliflozin) for Heart Failure

  • February 9, 2023
LEO Pharma’s Adtralza (tralokinumab) Receives the Health Canada’s Approval for the Treatment of Atopic Dermatitis

LEO Pharma’s Adtralza (tralokinumab) Receives the Health Canada’s Approval for the Treatment of Atopic Dermatitis

  • February 9, 2023
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.